Jackson Square Capital, LLC Bristol Myers Squibb CO Transaction History

Jackson Square Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $216,778 - $259,936	3,526 Added 79.67%	7,952 $581,000
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $2.13 Million - $2.48 Million	-39,689 Reduced 89.97%	4,426 $276,000
Q3 2021 Oct 21, 2021	SELL	$59.17 - $69.31 $37,336 - $43,734	-631 Reduced 1.41%	44,115 $2.61 Million
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $6,686 - $7,281	-108 Reduced 0.24%	44,746 $2.99 Million
Q1 2021 May 18, 2021	SELL	$59.34 - $66.74 $139,923 - $157,372	-2,358 Reduced 4.99%	44,854 $2.83 Million
Q4 2020 Mar 05, 2021	SELL	$57.74 - $65.43 $48,790 - $55,288	-845 Reduced 1.76%	47,212 $2.93 Million
Q3 2020 Nov 17, 2020	SELL	$57.43 - $63.64 $45,082 - $49,957	-785 Reduced 1.61%	48,057 $2.9 Million
Q2 2020 Aug 18, 2020	BUY	$54.82 - $64.09 $585,642 - $684,673	10,683 Added 28.0%	48,842 $2.87 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $1.64 Million - $2.38 Million	35,316 Added 1242.21%	38,159 $2.13 Million
Q4 2019 May 15, 2020	BUY	$49.21 - $64.19 $139,904 - $182,492	2,843 New	2,843 $182,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.